These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 328245)

  • 1. The indoleamine hypothesis of depression: an overview and pilot study.
    Zarcone VP; Berger PA; Brodie KH; Sack R; Barchas JD
    Dis Nerv Syst; 1977 Aug; 38(8):646-53. PubMed ID: 328245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of 5-hydroxyindole compounds during L-5-HTP treatment in depressed patients.
    Takahashi S; Takahashi R; Masumura I; Miike A
    Folia Psychiatr Neurol Jpn; 1976; 30(4):461-73. PubMed ID: 1087913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin and myoclonus.
    Van Woert MH; Jutkowitz R; Rosenbaum D; Bowers MB
    Monogr Neural Sci; 1976; 3():71-80. PubMed ID: 790170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin a la carte: supplementation with the serotonin precursor 5-hydroxytryptophan.
    Turner EH; Loftis JM; Blackwell AD
    Pharmacol Ther; 2006 Mar; 109(3):325-38. PubMed ID: 16023217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship of serotonin to depression in Parkinson's disease.
    Mayeux R; Stern Y; Sano M; Williams JB; Cote LJ
    Mov Disord; 1988; 3(3):237-44. PubMed ID: 2461509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and metabolic observations on the treatment of myoclonus with L-5-HTP and carbidopa.
    Thal L; Sharpless N; Wolfson L; Engel J; Katzman R
    Trans Am Neurol Assoc; 1976; 101():48-52. PubMed ID: 1088459
    [No Abstract]   [Full Text] [Related]  

  • 7. The Harold E. Himwich Memorial Lecture. Significance of biochemical parameters in the diagnosis, treatment, and prevention of depressive disorders.
    Praag HM
    Biol Psychiatry; 1977 Feb; 12(1):101-31. PubMed ID: 300032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotoninergic dysfunction in the 47, XYY syndrome.
    Bioulac B; Benezech M; Renaud B; Noel B; Roche D
    Biol Psychiatry; 1980 Dec; 15(6):917-23. PubMed ID: 6161648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of depression with serotonin precursors.
    van Praag HM
    Biol Psychiatry; 1981 Mar; 16(3):291-310. PubMed ID: 6164407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central serotonin deficiency--a factor which increases depression vulnerability?
    van Praag HM; de Haan S
    Acta Psychiatr Scand Suppl; 1980; 280():89-96. PubMed ID: 6157306
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of myoclonus with L-5-hydroxytryptophan and carbidopa: clinical, electrophysiological, and biochemical observations.
    Thal LJ; Sharpless NS; Wolfson L; Katzman R
    Ann Neurol; 1980 Jun; 7(6):570-6. PubMed ID: 6969054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoamine metabolism and depression in Parkinson patients.
    Puite JK; Schut T; van Praag HM; Lakke JP
    Psychiatr Neurol Neurochir; 1973; 76(1):61-70. PubMed ID: 4699106
    [No Abstract]   [Full Text] [Related]  

  • 13. 5-Hydroxytryptophan and carbidopa in spontaneously hypertensive rats.
    Itskovitz HD; Werber JL; Sheridan AM; Brewer TF; Stier CT
    J Hypertens; 1989 Apr; 7(4):311-5. PubMed ID: 2786023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of 5-hydroxyindole compounds during L-5-HTP treatment in depressed patients.
    Takahashi S; Takahashi R; Masumura I; Miike A
    Folia Psychiatr Neurol Jpn; 1976; 30(4):463-73. PubMed ID: 1088138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of l-5-hydroxytryptophan on brain monoamine metabolism and evaluation of its clinical effect in depressed patients.
    Takahashi S; Kondo H; Kato N
    J Psychiatr Res; 1975 Nov; 12(3):177-87. PubMed ID: 1081591
    [No Abstract]   [Full Text] [Related]  

  • 16. 5-Hydroxytrytophan as an antidepressant. The predictive value of the probenecid test.
    van Praag HM; Korf J
    J Nerv Ment Dis; 1974 May; 158(5):331-7. PubMed ID: 4596091
    [No Abstract]   [Full Text] [Related]  

  • 17. 5-Hydroxytryptophan: a review of its antidepressant efficacy and adverse effects.
    Byerley WF; Judd LL; Reimherr FW; Grosser BI
    J Clin Psychopharmacol; 1987 Jun; 7(3):127-37. PubMed ID: 3298325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depression: new evidence in support of biological differentiation.
    Garfinkel PE; Warsh JJ; Stancer HC
    Am J Psychiatry; 1979 Apr; 136(4B):535-9. PubMed ID: 426139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of L-5-hydroxytryptophan on monoamine and amino acids turnover in the Lesch-Nyhan syndrome.
    Castells S; Chakrabarti C; Winsberg BG; Hurwic M; Perel JM; Nyhan WL
    J Autism Dev Disord; 1979 Mar; 9(1):95-103. PubMed ID: 312282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Indoleamine precursors in depression (author's transl)].
    Coppen A; Wood K
    Encephale; 1979; 5(5 Suppl):627-32. PubMed ID: 95009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.